[en] Background. Several chemoattractants have been measured in exhaled breath condensate (EBC) from patients with COPD. The aim of this study was to compare the eosinophil. and neutrophil chemotactic activity contained in EBC from healthy subjects and patients with COPD. Methods: EBC collected using a commercially available condenser (EcoScreen; Erich Jaeger Viasys; Hoechberg, Germany) was compared in 45 COPD patients and 65 healthy subjects. EBC chemotactic activity for eosinophils and neutrophils was assessed using microchambers (Boyden; Neuro Probe; Cabin John, MD). Chemotactic index (CI) was used to evaluate cell migration. Results: EBC from patients with COPD (C1, 2.21 +/- 0.16 [mean +/- SEM]) and healthy subjects (CI, 1.67 +/- 0.11) displayed significant neutrophil chemotactic activity (p < 0.0001 for both), which was however higher in patients with COPD (p < 0.001). Healthy smokers had a significantly raised C1 for neutrophils by comparison with healthy nonsmokers (p < 0.01) and ex-smokers (p < 0.05). Ukewise, current COPD smokers tended to have greater neutrophil C1 than COPD who stopped smoking (p = 0.08). COPD ex-smokers had raised chemotactic activity by comparison with healthy ex-smokers (p < 0.05). Anti-interleuldn-8 (10(-6) g/mL) antibodies reduced neutrophil chemotactic activity by 35.2% (p < 0.05). EBC also contained significant eosinophil chemotactic activity in healthy subjects (CI, 1.68 0.09; p < 0.0001) and patients with COPD (CI, 1.23 +/- 0.07; p < 0.01), with a significantly lower CI in patients with COPD as compared to healthy subjects (p < 0.001). Smoking did not influence eosinophil chemotactic activity in healthy subjects or patients with COPD. Conclusions: Current smoking favors neutrophil chemotactic activity. As compared to healthy subjects, EBC from patients with COPD displays a skewed chemotactic activity toward neutrophils vs eosinophils.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Corhay, Jean-Louis ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Hemelaers
Henket, Monique ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Sele, Jocelyne ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Language :
English
Title :
Granulocyte chemotactic activity in exhaled breath condensate of healthy subjects and patients with COPD
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Beeh KM, Koornmann O, Buhl R, et al. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B 4. Chest 2003; 123:1240-1247
Montuschi P. Exhaled breath condensate analysis in patients with COPD. Clin Chim Acta 2005; 356:22-34
Horváth I, Hunt J, Barnes PJ, on behalf of the ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26:523-548
Montuschi P, Kharitonov SA, Ciabattoni G. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58:585-588
Bieniacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B 4 and 8-isoprostane in exhaled breath condensate of patients with exacerbation of COPD. Thorax 2003; 58:294-298
Kostikas K, Gaga M, Papatheodorou G, et al. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127:1553-1559
Cunningham S, McColm JR, Ho LP, et al. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J 2000; 15: 955-957
Simpson JL, Wood LG, Gibson PC. Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy 2005; 35:1180-1185
Garey K, Neuhauser MM, Robbins RA, et al. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004; 125:22-26
Sutherland ER, Martin RJ. Airway inflammation in chronic obstructive pulmonaiy disease; comparisons with asthma. J Allergy Clin Immunol 2003; 112:819-827
Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop report. Am J Respir Crit Care Med 2001; 163:1256-1276 (updated 2003; available at www.goklcopd.com. Accessed December 19, 2003)
Hatzelmann A, Tenor H, Schudt C. Differential effects of nonselective and selective phosphodiesterase inhibitor on human cosinophil function. Br J Pharmacol 1995; 114:821-831
Effros RM, Biller J, Foss B, et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 2003; 168:1500-1505
Garcia A, McHugh M, Ballering JG, et al. Neutrophils, protein, and LTB4 are increased in sputum compared to bronchoalveolar lavage and exhaled breath condensate [abstract]. Am J Respir Crit Care Med 2005; A844
Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lung of cigarette smokers. Am Rev Respir Dis 1983; 128:S33-S3S
Thomas RA, Green RH, Brightling CE, et al. The influence of age on induced sputum differential cell counts in normal subjects. Chest 2004; 126:1811-1814
Thurlbeck WM. Pathology of chronic obstructive pulmonary disease. Clin Chest Med 1990; 11:389-404
Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158:1277-1285
Ronchi MC, Piragino C, Rosi E, et al. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996; 51:1000-1004
Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121:151-155
Confalonieri M, Mainardi E, Della Porta R, et al. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonaiy disease. Thorax 1998; 53:583-585
Yildiz F, Kaur AC, Ilgazli A, et al. Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease. Respiration 2000; 67:71-76
Llewellyn-Jones CG, Harris TA, Stockley RA. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 1996; 153:616-621
Llewellyn-Jones CG, Hill SL, Stockley RA. Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro. Thorax 1994; 49:207-212
Culpitt SV, Maziak W, Loukadis S, et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 160:1635-1639
Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542-548
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.